RecensMedical, Inc. (KOSDAQ:394420)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,250
+490 (5.02%)
At close: Sep 4, 2026

RecensMedical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-11,046-19,119-7,844-7,572-40,994
Depreciation & Amortization
621.7509.91388.72524.36424.46
Loss (Gain) From Sale of Assets
4.55--66.17-
Stock-Based Compensation
969.81841.38442.161,8861,642
Provision & Write-off of Bad Debts
458.79423.811,738158.07-
Other Operating Activities
322.729,213-5,550-4,65921,955
Change in Accounts Receivable
-1,605-1,232-1,123-3,266-15.4
Change in Inventory
-1,377271.062,090-705.44-4,591
Change in Accounts Payable
480.46468.91-462.51355.64-191.34
Change in Other Net Operating Assets
-96.7628.73587.32-65.8-251.05
Operating Cash Flow
-11,266-8,594-9,733-13,278-22,022
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-1,136-760.59-482.58-251.62-717.77
Sale of Property, Plant & Equipment
--0.15--
Sale (Purchase) of Intangibles
-106.92-46.25-4.6-1.87-184.3
Investment in Securities
-7,3435,000-5,0007,033-6,533
Other Investing Activities
-62.29211.1464.04-20-19.69
Investing Cash Flow
-8,6484,404-5,4236,743-7,454

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Short-Term Debt Issued
-950---
Long-Term Debt Issued
----500
Total Debt Issued
7,950950--500
Short-Term Debt Repaid
--950---
Long-Term Debt Repaid
--330.23-285.2-414.17-293.49
Total Debt Repaid
-3,334-1,280-285.2-414.17-293.49
Net Debt Issued (Repaid)
4,616-330.23-285.2-414.17206.51
Issuance of Common Stock
17,202338.54727.8876.433.9
Other Financing Activities
--0--6.42-
Financing Cash Flow
21,8188.3117,724-344.1935,202

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
256.24-127.68157.0748.64-81.93
Net Cash Flow
2,160-4,3092,725-6,8315,643

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-12,402-9,354-10,215-13,530-22,740
Free Cash Flow Growth
-----
Free Cash Flow Margin
-190.19%-105.95%-163.20%-234.47%-8070.77%
Free Cash Flow Per Share
-1263.87-1413.99-2984.99-4079.06-6885.21
Levered Free Cash Flow
--77,913-19,126-19,248-
Unlevered Free Cash Flow
--76,408-16,690-17,333-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Interest Paid
170.3356.5338.97112.82-
Cash Income Tax Paid
-26.6-26.8913.845.7
Change in Working Capital
-2,598-462.911,092-3,682-5,049